{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T20:53:49Z","timestamp":1772657629354,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejmech.2022.114196","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T11:17:24Z","timestamp":1645615044000},"page":"114196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Discovery of novel ataxia telangiectasia mutated (ATM) kinase modulators: Computational simulation, biological evaluation and cancer combinational chemotherapy study"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4064-1051","authenticated-orcid":false,"given":"Xiaodong","family":"Dou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zefang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6446-8786","authenticated-orcid":false,"given":"Yameng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongtang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiwang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-4015","authenticated-orcid":false,"given":"Zhenming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114196_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2022.114196_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2015.12.009","article-title":"ATM kinase: much more than a DNA damage responsive protein","volume":"39","author":"Guleria","year":"2016","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejmech.2022.114196_bib3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A\u00a0single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114196_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114196_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","article-title":"DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation","volume":"421","author":"Bakkenist","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114196_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2006.01.026","article-title":"The role of NBS1 in the modulation of PIKK family proteins ATM and ATR in the cellular response to DNA damage","volume":"243","author":"Zhou","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2022.114196_bib7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114196_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.genet.31.1.635","article-title":"Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart","volume":"31","author":"Shiloh","year":"1997","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ejmech.2022.114196_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cancergencyto.2010.03.006","article-title":"Interaction between BRCA1\/BRCA2 and ATM\/ATR associate with breast cancer susceptibility in a Chinese Han population","volume":"200","author":"Wang","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.ejmech.2022.114196_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0026-895X(24)12324-3","article-title":"Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin","volume":"61","author":"Wu","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114196_bib11","first-page":"5","article-title":"Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors","author":"Yamamoto","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2022.114196_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.apsb.2012.06.005","article-title":"Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus","volume":"2","author":"Wang","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2022.114196_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/1535-7163.MCT-12-0707","article-title":"Preclinical evaluation of a novel ATM inhibitor, KU59403, in\u00a0vitro and in\u00a0vivo in p53 functional and dysfunctional models of human cancer","volume":"12","author":"Batey","year":"2013","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2022.114196_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030687","article-title":"ATM-deficient cancers provide new opportunities for precision oncology","volume":"12","author":"Jette","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2022.114196_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrc3342","article-title":"The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance","volume":"12","author":"Bouwman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2022.114196_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/09553002.2015.1001531","article-title":"The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect","volume":"91","author":"Zhang","year":"2015","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ejmech.2022.114196_bib17","doi-asserted-by":"crossref","first-page":"E6669","DOI":"10.1073\/pnas.1603876113","article-title":"ATM\/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia","volume":"vol. 113","author":"Gregory","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2022.114196_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114196_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2016.12.040","article-title":"The depletion of ATM inhibits colon cancer proliferation and migration via B56 gamma 2-mediated Chkl\/p53\/CD44 cascades","volume":"390","author":"Liu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2022.114196_bib20","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jmedchem.6b00519","article-title":"Discovery of novel 3-quinoline carboxamides as potent, selective, and orally bioavailable inhibitors of ataxia telangiectasia mutated (ATM) kinase","volume":"59","author":"Degorce","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib21","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jmedchem.6b00519","article-title":"Discovery of novel 3-quinoline carboxamides as potent, selective, and orally bioavailable inhibitors of ataxia telangiectasia mutated (ATM) kinase","volume":"59","author":"Degorce","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib22","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2016-3041","article-title":"Blood-brain barrier penetrating ATM inhibitor (AZ32) radiosensitises intracranial gliomas in mice","volume":"76","author":"Durant","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2022.114196_bib23","doi-asserted-by":"crossref","first-page":"73925","DOI":"10.18632\/oncotarget.18034","article-title":"Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity","volume":"8","author":"Dohmen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2022.114196_bib24","article-title":"Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2022.114196_bib25","series-title":"Clinical Potential of ATM Inhibitors, Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis","first-page":"111695","author":"Lavin","year":"2020"},{"key":"10.1016\/j.ejmech.2022.114196_bib26","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","article-title":"Identification and characterization of a novel and specific inhibitor of the ataxiatelangiectasia mutated kinase ATM","volume":"64","author":"Ian Hickson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2022.114196_bib27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/jm061121y","volume":"50","author":"Hollick","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib28","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-09-0519","article-title":"Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion","volume":"8","author":"Golding","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2022.114196_bib29","author":"NCT03571438"},{"key":"10.1016\/j.ejmech.2022.114196_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biocel.2017.03.015","article-title":"The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a gammaH2AX\/p-p53\/caspase-3-independent mechanism: inhibition of calpain and cathepsin D","volume":"87","author":"Chwastek","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114196_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcimb.2019.00026","article-title":"Evaluation of ATM kinase inhibitor KU-55933 as potential anti-toxoplasma gondii agent","volume":"9","author":"Munera Lopez","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114196_bib32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ijc.28680","article-title":"Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019","volume":"135","author":"Vecchio","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2022.114196_bib33","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1158\/0008-5472.CAN-08-0763","article-title":"Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation","volume":"68","author":"Rainey","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2022.114196_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/acs.jmedchem.5b01092","article-title":"Optimization of a novel series of ataxia-telangiectasia mutated kinase inhibitors as potential radiosensitizing agents","volume":"59","author":"Min","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib35","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1158\/1535-7163.MCT-17-0975","article-title":"Orally bioavailable and blood-brain barrier-penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice","volume":"17","author":"Karlin","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2022.114196_bib36","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1021\/acs.jmedchem.7b01896","volume":"61","author":"Pike","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","volume":"4","author":"Durant","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2022.114196_bib38","author":"NCT02588105"},{"key":"10.1016\/j.ejmech.2022.114196_bib39","author":"NCT03215381"},{"key":"10.1016\/j.ejmech.2022.114196_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","article-title":"Ultra-large library docking for discovering new chemotypes","volume":"566","author":"Lyu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114196_bib41","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/acs.jmedchem.9b00537","article-title":"Multistage screening reveals 3-substituted indolin-2-one derivatives as novel and isoform-selective c-Jun N-terminal kinase 3 (JNK3) inhibitors: implications to drug discovery for potential treatment of neurodegenerative diseases","volume":"62","author":"Dou","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejmech.2017.02.020","article-title":"Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening","volume":"129","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib43","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/ci500062f","article-title":"An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs","volume":"54","author":"Xia","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2022.114196_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41594-021-00654-x","article-title":"Molecular basis of human ATM kinase inhibition","volume":"28","author":"Stakyte","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114196_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejmech.2019.03.039","article-title":"Discovery of novel glycogen synthase kinase-3alpha inhibitors: structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia","volume":"171","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib46","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acsmedchemlett.8b00200","article-title":"Discovery of a series of 3-cinnoline carboxamides as orally bioavailable, highly potent, and selective ATM inhibitors","volume":"9","author":"Barlaam","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114196_bib47","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","article-title":"ATM mutations in cancer: therapeutic implications","volume":"15","author":"Choi","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2022.114196_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/jm501026z","article-title":"Phosphatidylinositol 3-Kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors: importance of the morpholine ring","volume":"58","author":"Andrs","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib49","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.bmc.2019.05.044","article-title":"Small molecule inhibition of microRNA-21 expression reduces cell viability and microtumor formation","volume":"27","author":"Ankenbruck","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib50","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1016\/j.bmcl.2014.07.028","article-title":"Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor","volume":"24","author":"Liu","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114196_bib51","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/leu.2016.325","article-title":"Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma","volume":"31","author":"Qin","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2022.114196_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.dnarep.2010.11.005","article-title":"Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-kappaB activation","volume":"10","author":"Veuger","year":"2011","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejmech.2022.114196_bib53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/09553002.2015.1001531","article-title":"The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect","volume":"91","author":"Zhang","year":"2015","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ejmech.2022.114196_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biocel.2017.03.015","article-title":"The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a gamma H2AX\/p-p53\/caspase-3-independent mechanism: inhibition of calpain and cathepsin D","volume":"87","author":"Chwastek","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114196_bib55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.sbi.2019.12.010","article-title":"Structures and regulations of ATM and ATR, master kinases in genome integrity","volume":"61","author":"Williams","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2022.114196_bib56","first-page":"12","article-title":"Cell death and survival pathways involving ATM protein kinase","author":"Aki","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.ejmech.2022.114196_bib57","first-page":"607","article-title":"The same, only different - DNA damage checkpoints and their reversal throughout the cell cycle","volume":"128","author":"Shaltiel","year":"2015","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2022.114196_bib58","doi-asserted-by":"crossref","first-page":"101163","DOI":"10.1016\/j.jbc.2021.101163","article-title":"Inhibition of nonsense-mediated decay rescues p53\u03b2\/\u03b3 isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers","volume":"297","author":"Gudikote","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114196_bib59","doi-asserted-by":"crossref","first-page":"707734","DOI":"10.3389\/fimmu.2021.707734","article-title":"Promising new tools for targeting p53 mutant cancers: humoral and cell-based immunotherapies","volume":"12","author":"Chasov","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2022.114196_bib60","series-title":"LigPrep, Version 2.3; Schrodinger","year":"2015"},{"key":"10.1016\/j.ejmech.2022.114196_bib61","series-title":"Epic, Version 3.2; Schrodinger","year":"2015"},{"key":"10.1016\/j.ejmech.2022.114196_bib62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bmcl.2017.11.036","article-title":"Discovery of new GSK-3beta inhibitors through structure-based virtual screening","volume":"28","author":"Dou","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114196_bib63","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/1087057113520325","article-title":"Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors","volume":"19","author":"Guo","year":"2014","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2022.114196_bib64","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:38:34Z","timestamp":1759329514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":64,"alternative-id":["S0223523422000988"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114196","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel ataxia telangiectasia mutated (ATM) kinase modulators: Computational simulation, biological evaluation and cancer combinational chemotherapy study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114196"}}